0341 GMT - Raffles Medical Group is likely to benefit from its strategic collaboration with Renji Hospital affiliated to Shanghai Jiao Tong University School of Medicine, Maybank Research's Eric Ong says, noting the recent signing of an agreement. The two entities agreed to establish a "dual circulation" medical resource service system, to advance a new model of collaborative development and promote Shanghai as an international medical tourism hub, the analyst says. Raffles Medical Group's international-standard service system will be integrated into China's domestic healthcare system, the analyst adds. The brokerage raises the stock's target price to S$1.13 from S$1.03, with an unchanged buy rating. Shares are unchanged at S$1.01. (ronnie.harui@wsj.com)
(END) Dow Jones Newswires
April 23, 2025 23:41 ET (03:41 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。